STOCK TITAN

Mink Brook entities report 190,596 shares in Ekso Bionics (NASDAQ: EKSO)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Mink Brook reporting persons report beneficial ownership of 190,596 shares (5.4%) of Ekso Bionics common stock. As of the close of business on April 8, 2026, Mink Brook Partners LP held 190,596 shares. The filing states shared voting and shared dispositive power among Mink Brook Capital GP LLC, Mink Brook Asset Management LLC, and William Mueller. The percentage is calculated using 3,563,381 shares outstanding as of February 23, 2026 disclosed in the company’s Form 10-K; the filers include a disclaimer of beneficial ownership except to the extent of pecuniary interest.

Positive

  • None.

Negative

  • None.
Shares held by Mink Brook Partners LP 190,596 shares held as of April 8, 2026
Percent of class 5.4% calculated using 3,563,381 shares outstanding as of February 23, 2026
Shares outstanding used for calculation 3,563,381 shares as of February 23, 2026 (Form 10-K)
beneficially owned regulatory
"Amount beneficially owned: As of the close of business on April 8th, 2026"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive power regulatory
"Shared Dispositive Power 190,596.00"
Section 13(d) regulatory
"deemed to constitute an admission ... for purposes of Section 13(d)"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





282644400

(CUSIP Number)
04/08/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 3,563,381 shares outstanding as of 2/23/26 disclosed in the company's Form 10-K


SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 3,563,381 shares outstanding as of 2/23/26 disclosed in the company's Form 10-K


SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 3,563,381 shares outstanding as of 2/23/26 disclosed in the company's Form 10-K


SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 3,563,381 shares outstanding as of 2/23/26 disclosed in the company's Form 10-K


SCHEDULE 13G



Mink Brook Partners LP
Signature:/s/ William Mueller
Name/Title:Managing Member, general partner Mink Brook Capital GP LLC
Date:04/09/2026
Mink Brook Capital GP LLC
Signature:/s/ William Mueller
Name/Title:Managing Member, general partner Mink Brook Capital GP LLC
Date:04/09/2026
William Mueller
Signature:/s/ William Mueller
Name/Title:Managing Member, Mink Brook Capital GP LLC
Date:04/09/2026
Mink Brook Asset Management LLC
Signature:/s/ William Mueller
Name/Title:Managing Member, Mink Brook Asset Management LLC
Date:04/09/2026

FAQ

What stake does Mink Brook Partners hold in EKSO?

Mink Brook Partners LP holds 190,596 shares, equal to 5.4% of Ekso Bionics. The percentage uses 3,563,381 shares outstanding as of February 23, 2026 per the Form 10-K; the position is reported as shared voting and dispositive power.

Who else is listed with shared power over the EKSO shares?

Mink Brook Capital GP LLC, Mink Brook Asset Management LLC, and William Mueller are listed as having shared voting and shared dispositive power over 190,596 shares. The filings state these relationships reflect managerial roles and include a limited ownership disclaimer.

What date is the ownership based on in the Schedule 13G filing?

The ownership amount is reported as of the close of business on April 8, 2026. The percentage calculation references 3,563,381 shares outstanding as of February 23, 2026, per the company’s Form 10-K.

Does the filing claim sole voting or sole dispositive power for these shares?

No. Each filer reports 0 shares of sole voting power and sole dispositive power and 190,596 shares of shared voting and shared dispositive power.

Is the reporting person admitting beneficial ownership under Section 13(d)?

No. The filing explicitly disclaims that William Mueller and Mink Brook Capital GP LLC are the beneficial owners for purposes of Section 13(d), except to the extent of any pecuniary interest, per the filing language.